It was fantastic to see representatives of our investors, Synova, Zachary Tsai and Mike Mullally on-site yesterday, Thursday 5 August 2022, alongside Charnwood Molecular Chairman Ben Cons.

Joining them for an informal lunch were colleagues from all areas of the business: biology, medicinal chemistry, computational chemistry, DMPK, analytical, process chemistry, finance, marketing, operations, business support and talent acquisition.

There were many topics of conversation, with everyone getting an insight into the role each plays in the business, whether as an investor or member of staff.

We look forward to similar events taking place in the future.